Accelerating the Development of Gamma Delta T Therapies in Oncology

Join us on Wednesday, September 30, to discuss the precise mechanisms of γδT cells, examine donor selection for allogeneic therapies, and deliberate the targeting of solid tumours.

As we virtually gather world-leading researchers at the Gamma Delta T Therapies Summit, learn how the industry is effectively manipulating and engineering gamma delta cells with antibody and cell-based approaches for improved safety, efficacy and manufacturability to bring to market effective Gamma Delta Therapies for patients in need.

With a unique opportunity to pose questions to experts and gain fresh insights on such a fast paced and growing field in a live Q&A, this digital event is not to be missed.

Find out more about the event and to see participation opportunities: https://ter.li/qk6gc1